Penile Rehabilitation Effectiveness After Prostate Cancer Treatment: A Systematic Review of Randomized Controlled Trials

Overview

Journal Narra J

Specialties Public Health
Tropical Medicine

Date 2024 Mar 8

PMID 38454969

Authors

Roshan Prasad

Mayur Wanjari

Yeshwant R Lamture

Sampada Late

Ranjana Sharma

Affiliations

Soon will be listed here.

Abstract

Prostate cancer treatment can significantly impact erectile function, and penile rehabilitation has been proposed to improve the impacts. However, the effectiveness of penile rehabilitations after treatment of prostate cancer is scarce. The aim of this systematic review was to evaluate the effectiveness of different interventions of penile rehabilitation program after prostate cancer treatment. We conducted a comprehensive search of electronic databases, PubMed and Google Scholar, to identify randomized controlled trials that evaluated interventions for penile rehabilitation after prostate cancer treatment. Studies that met our inclusion criteria were systematically reviewed, and data were synthesized and analyzed. We identified 11 randomized controlled trials that evaluated different interventions for penile rehabilitation after prostate cancer treatment. The interventions included the use of phosphodiesterase type 5 inhibitors, intracavernous injections, vacuum erection devices, and penile rehabilitation programs. The data suggest that these phosphodiesterase inhibitors, intracavernous injections, vacuum erection devices, and penile rehabilitation programs are promising in improving erectile function after prostate cancer treatment. However, the optimal timing and duration of these interventions remain unclear, and there is a need for further research to determine their long-term effectiveness and safety. Healthcare providers should consider individualized approaches to penile rehabilitation, taking into account patient characteristics and preferences.

References

Fode M, Borre M, Ohl D, Lichtbach J, Sonksen J . Penile vibratory stimulation in the recovery of urinary continence and erectile function after nerve-sparing radical prostatectomy: a randomized, controlled trial. BJU Int. 2013; 114(1):111-7. PMC: 4282032. DOI: 10.1111/bju.12501. View

Taylor K, Luta G, Miller A, Church T, Kelly S, Muenz L . Long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trial. J Clin Oncol. 2012; 30(22):2768-75. PMC: 4166119. DOI: 10.1200/JCO.2011.41.2767. View

Clavell-Hernandez J, Wang R . Penile rehabilitation following prostate cancer treatment: review of current literature. Asian J Androl. 2015; 17(6):916-22. PMC: 4814961. DOI: 10.4103/1008-682X.150838. View

Huang S, Lie J . Phosphodiesterase-5 (PDE5) Inhibitors In the Management of Erectile Dysfunction. P T. 2013; 38(7):407-19. PMC: 3776492. View

Lane J, Donovan J, Young G, Davis M, Walsh E, Avery K . Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study). BJU Int. 2022; 130(3):370-380. PMC: 9543725. DOI: 10.1111/bju.15739. View

Philippou Y, Jung J, Steggall M, ODriscoll S, Bakker C, Bodie J . Penile rehabilitation for postprostatectomy erectile dysfunction. Cochrane Database Syst Rev. 2018; 10:CD012414. PMC: 6517112. DOI: 10.1002/14651858.CD012414.pub2. View

Siegel R, Miller K, Fuchs H, Jemal A . Cancer Statistics, 2021. CA Cancer J Clin. 2021; 71(1):7-33. DOI: 10.3322/caac.21654. View

Baker L, Hanks G, Gershenson D, Kantoff P, Lange P, Logothetis C . NCCN Prostate Cancer Practice Guidelines. The National Comprehensive Cancer Network. Oncology (Williston Park). 1996; 10(11 Suppl):265-88. View

Nelson C, Saracino R, Napolitano S, Pessin H, Narus J, Mulhall J . Acceptance and Commitment Therapy to Increase Adherence to Penile Injection Therapy-Based Rehabilitation After Radical Prostatectomy: Pilot Randomized Controlled Trial. J Sex Med. 2019; 16(9):1398-1408. PMC: 6943977. DOI: 10.1016/j.jsxm.2019.05.013. View

10.

Sterne J, Savovic J, Page M, Elbers R, Blencowe N, Boutron I . RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019; 366:l4898. DOI: 10.1136/bmj.l4898. View

11.

Chiles K, Staff I, Johnson-Arbor K, Champagne A, McLaughlin T, Graydon R . A Double-Blind, Randomized Trial on the Efficacy and Safety of Hyperbaric Oxygenation Therapy in the Preservation of Erectile Function after Radical Prostatectomy. J Urol. 2017; 199(3):805-811. DOI: 10.1016/j.juro.2017.10.016. View

12.

Kim D, Hawksworth D, Hurwitz L, Cullen J, Rosner I, Lue T . A prospective, randomized, placebo-controlled trial of on-Demand vs. nightly sildenafil citrate as assessed by Rigiscan and the international index of erectile function. Andrology. 2015; 4(1):27-32. DOI: 10.1111/andr.12118. View

13.

Montorsi F, Brock G, Lee J, Shapiro J, van Poppel H, Graefen M . Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol. 2008; 54(4):924-31. DOI: 10.1016/j.eururo.2008.06.083. View

14.

Montorsi F, Brock G, Stolzenburg J, Mulhall J, Moncada I, Patel H . Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT). Eur Urol. 2013; 65(3):587-96. DOI: 10.1016/j.eururo.2013.09.051. View

15.

Tal R, Stember D, Logmanieh N, Narus J, Mulhall J . Erectile dysfunction in men treated for testicular cancer. BJU Int. 2013; 113(6):907-10. DOI: 10.1111/bju.12331. View

16.

Martins F, Padma-Nathan H . Diffuse veno-occlusive dysfunction: the underlying hemodynamic abnormality resulting in failure to respond to intracavernous pharmacotherapy. J Urol. 1996; 156(6):1942-6. DOI: 10.1016/s0022-5347(01)65400-4. View

17.

Mulhall J, Klein E, Slawin K, Henning A, Scardino P . A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Utility of Tacrolimus (FK506) for the Prevention of Erectile Dysfunction Following Bilateral Nerve-Sparing Radical Prostatectomy. J Sex Med. 2018; 15(9):1293-1299. DOI: 10.1016/j.jsxm.2018.07.009. View

18.

Carrie C, Magne N, Burban-Provost P, Sargos P, Latorzeff I, Lagrange J . Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial. Lancet Oncol. 2019; 20(12):1740-1749. DOI: 10.1016/S1470-2045(19)30486-3. View

19.

Milios J, Ackland T, Green D . Pelvic floor muscle training in radical prostatectomy: a randomized controlled trial of the impacts on pelvic floor muscle function and urinary incontinence. BMC Urol. 2019; 19(1):116. PMC: 6858748. DOI: 10.1186/s12894-019-0546-5. View

20.

Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A . Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol. 2009; 28(1):126-31. DOI: 10.1200/JCO.2009.24.2180. View